Two More Disease Team Applications Sent Back for More Review
Directors of the California stem cell agency today referred two additional research applications for $37 million in disease team funding back to reviewers for further consideration.
Both were the subjects of appeals by researchers whose proposals were rejected by grant reviewers.
One was from Timothy Hoey of OncoMed Pharmaceuticals in Redwood City, who so…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.